Just published… Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular edema: a real-world analysis of 28 658 patient eyes
Just published…This first FDA-approved gene therapy for a hereditary genetic disease, marks a new cycle of therapeutic innovation, especially for inherited retinal disease & potentially for common disorders, such as AMD & diabetic retinopathy. Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for …
Just published this article on cost effectiveness analysis…
Cost Effectiveness Analysis in Retina. New Onetime Treatments Require New Reimbursement Models
Recently co-authored this paper on a new potential therapeutic target…Investigational Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema: An Expert Assessment
[ad_1] Just published…Diabetic macular edema, a leading cause of vision loss, is treated less intensely and shows worse outcomes than in clinical trials. More effective and longer acting therapies are needed. A Real-World Analysis of 28,658 Patient Eyes… https://t.co/4VaRq6BYQX [ad_2] Source by Thomas Ciulla, MD, …
[ad_1]
Now in press & online @ Ophthalmology, the journal of the American Academy of Ophthalmology, the first phase 3 trial to evaluate suprachoroidal injection for treatment of an ocular disease…
https://t.co/hgCc9WHHdu
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Disruption brings harmony in biotech: The rise of anti-VEGF therapy shows what industry, academia, private practice can create together. https://t.co/WwBCk4kkr8 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @OphthalmicPro: Are you curious about gene therapy? Check out Dr. Thomas Ciulla’s article at https://t.co/82jHtEhRGq #ophthalmology #eye… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @RetinalPhys: Clearside Biomedical said it has done significant preclinical testing of the anti-VEGF axitinib and plans to begin a clini…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] In San Francisco this week for the JP Morgan Healthcare Conference #jpm2020. Looking forward to connecting with old friends and colleagues. Please reach out if you want to catch up. [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.